N-(3-Methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-5-phenethyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-amine

Catalog No. :
ACGIDU592
CAS No. :
1077629-24-3
Molecular Formula :
C25H27N5OS
Molecular Weight :
445.59

IUPAC Name:N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-5-phenethyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-amine

N-(3-Methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-5-phenethyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$1011.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3-Methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-5-phenethyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-amine
IUPAC NameN-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-5-phenethyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-amine
Molecular FormulaC25H27N5OS
Molecular Weight445.59
SMILESCC1=CN(C2=CC=C(NC(S3)=NC4=C3CN(CCC5=CC=CC=C5)CC4)C=C2OC)C=N1
InChI KeyALKXDSKMNYVZFG-UHFFFAOYSA-N
SynonymN-(3-Methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-5-phenethyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-amine;Thiazolo[5,4-c]pyridin-2-amine, 4,5,6,7-tetrahydro-N-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]-5-(2-phenylethyl)-
CAS No.1077629-24-3

Synthetic Route by SureRoute

1. ACGIDU592 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGIDU592 route product structure diagram
    ACGIDU5921077629-24-3
Inquiry

2. ACGIDU592 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGIDU592 route product structure diagram
    ACGIDU5921077629-24-3
Inquiry

Comments (0)